|
1
|
Qiu D and Kao PN: Immunosuppressive and
anti-inflammatory mechanisms of triptolide, the principal active
diterpenoid from the Chinese medicinal herb Tripterygium wilfordii
Hook. f. Drugs R D. 4:1–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Corson TW and Crews CM: Molecular
understanding and modern application of traditional medicines:
Triumphs and trials. Cell. 130:769–774. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Efferth T, Li PC, Konkimalla VS and Kaina
B: From traditional Chinese medicine to rational cancer therapy.
Trends Mol Med. 13:353–361. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Westfall SD, Nilsson EE and Skinner MK:
Role of triptolide as an adjunct chemotherapy for ovarian cancer.
Chemotherapy. 54:67–76. 2008. View Article : Google Scholar
|
|
5
|
Chen L, Liu Q, Huang Z, Wu F, Li Z, Chen X
and Lin T: Tripchlorolide induces cell death in lung cancer cells
by autophagy. Int J Oncol. 40:1066–1070. 2012.
|
|
6
|
Jang BC, Lim KJ, Choi IH, Suh MH, Park JG,
Mun KC, Bae JH, Shin DH and Suh SI: Triptolide suppresses
interleukin-1beta-induced human beta-defensin-2 mRNA expression
through inhibition of transcriptional activation of NF-kappaB in
A549 cells. Int J Mol Med. 19:757–763. 2007.PubMed/NCBI
|
|
7
|
Westerheide SD, Kawahara TL, Orton K and
Morimoto RI: Triptolide, an inhibitor of the human heat shock
response that enhances stress-induced cell death. J Biol Chem.
281:9616–9622. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karin M, Cao Y, Greten FR and Li ZW:
NF-kappaB in cancer: From innocent bystander to major culprit. Nat
Rev Cancer. 2:301–310. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oya M, Takayanagi A, Horiguchi A, Mizuno
R, Ohtsubo M, Marumo K, Shimizu N and Murai M: Increased nuclear
factor-kappa B activation is related to the tumor development of
renal cell carcinoma. Carcinogenesis. 24:377–384. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baldwin AS: Control of oncogenesis and
cancer therapy resistance by the transcription factor NF-kappaB. J
Clin Invest. 107:241–246. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li H, Hui L, Xu W, et al: Triptolide
modulates the sensitivity of K562/A02 cells to adriamycin by
regulating miR-21 expression. Pharm Biol. 50:1233–1240. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen YW, Lin GJ, Chuang YP, Shen H, Chen
Q, Long L and Zhu X: Triptolide circumvents drug-resistant effect
and enhances 5-fluorouracil antitumor effect on KB cells.
Anticancer Drugs. 21:502–513. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Edelman MJ: Novel taxane formulations and
microtubule-binding agents in non-small-cell lung cancer. Clin Lung
Cancer. 10(Suppl 1): S30–S34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weaver BA: How Taxol/paclitaxel kills
cancer cells. Mol Biol Cell. 25:2677–2681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kastl L, Brown I and Schofield AC: Altered
DNA methylation is associated with docetaxel resistance in human
breast cancer cells. Int J Oncol. 36:1235–1241. 2010.PubMed/NCBI
|
|
16
|
Yang S, Chen J, Guo Z, Xu XM, Wang L, Pei
XF, Yang J, Underhill CB and Zhang L: Triptolide inhibits the
growth and metastasis of solid tumors. Mol Cancer Ther. 2:65–72.
2003.PubMed/NCBI
|
|
17
|
Pietenpol JA and Stewart ZA: Cell cycle
checkpoint signaling: Cell cycle arrest versus apoptosis.
Toxicology. 181–182. 475–481. 2002.
|
|
18
|
Morales-Cano D, Calviño E, Rubio V,
Herráez A, Sancho P, Tejedor MC and Diez JC: Apoptosis induced by
paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4
human leukaemia cells is not modulated by ERK inhibition. Exp
Toxicol Pathol. 65:1101–1108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ryan KM, Ernst MK, Rice NR and Vousden KH:
Role of NF-kappaB in p53-mediated programmed cell death. Nature.
404:892–897. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Q and Verma IM: NF-kappaB regulation in
the immune system. Nat Rev Immunol. 2:725–734. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karin M and Lin A: NF-kappaB at the
crossroads of life and death. Nat Immunol. 3:221–227. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gilmore TD, Koedood M, Piffat KA and White
DW: RelNF-kappaBIkappaB proteins and cancer. Oncogene.
13:1367–1378. 1996.PubMed/NCBI
|
|
23
|
Deveraux QL, Roy N, Stennicke HR, Van
Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS and Reed
JC: IAPs block apoptotic events induced by caspase-8 and cytochrome
c by direct inhibition of distinct caspases. EMBO J. 17:2215–2223.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghosh S, May MJ and Kopp EB: NF-kappa B
and Rel proteins: Evolutionarily conserved mediators of immune
responses. Annu Rev Immunol. 16:225–260. 1998. View Article : Google Scholar : PubMed/NCBI
|
